Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia
Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia is a PHASE1 clinical asset sponsored by The Affiliated Hospital of the Chinese Academy of Military Medical Sciences in Safety Issues, Efficiency. SEO and diligence focus: microtransplantation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Safety Issues
Modality: protein therapy
Target: microtransplantation
Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: microtransplantation
View original source fields
Condition raw: Safety Issues, Efficiency
Condition normalized: Safety Issues, Efficiency
Modality raw: protein therapy
Modality normalized: protein therapy
Target raw: microtransplantation
Target normalized: microtransplantation